The folic acid biosynthesis pathway in bacteria: Evaluation of potential for antibacterial drug discovery

BioEssays

Volumn 24, Issue 7, 2002, Pages 637-648

  Bermingham, Alun ^a   Derrick, Jeremy P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; DRUG DESIGN; ENZYME INHIBITORS; FOLIC ACID; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SUPPORT, NON-U.S. GOV'T; ANIMALS; ANTI-BACTERIAL AGENTS;

BACTERIA (MICROORGANISMS);

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; ENZYME INHIBITOR; FOLIC ACID;

ANIMAL; BACTERIAL INFECTION; BACTERIUM; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN BINDING; PROTEIN QUATERNARY STRUCTURE; REVIEW;

EID: 0035996799     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10114     Document Type: Review

References (84)

1. Membrane-associated folate transport proteins
2. Replacement of the folC gene, encoding folylpolyglutamate synthetase-dihydrofolate synthetase in Escherichia coli, with genes mutagenized in vitro
3. Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: Kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli
4. The relationship of p-aminobenzic acid to the mechanism of the action of sulphanilamide
5. Pyrimidine derivatives as antagonists of pteroylglutamic acid
6. The biosynthesis of folic acid. I. Substrate and cofactor requirements for enzymatic synthesis by cell-free extracts of Escherichia coli
7. The biosynthesis of folic acid. VI. Enzymatic conversion of carbon atom 8 of guanosine triphosphate to formic acid
8. Characteristics of guanosine triphosphate cyclohydrolase I purified from Escherichia coli
9. Enzymatic epimerization of D-erythro-dihydroneopterin triphosphate to L-threo-dihydroneopterin triphosphate
10. The biosynthesis of folic acid. XI. Purification and properties of dihydroneopterin aldolase
11. The biosynthesis of folic acid. IV. Enzymatic synthesis of dihydrofolic acid from guanine and ribose compounds
12. The biosynthesis of folic acid. IX. Purification and properties of the enzymes required for the formation of dihydropteroic acid
13. The biosynthesis of folic acid. XII. Purification and properties of dihydroneopterin triphosphate pyrophosphohydrolase
14. A metabolic node in action: Chorismate-utilizing enzymes in microorganisms
15. Dihydrofolate reductase as a therapeutic target
16. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase
17. History and future of antimicrobial diaminopyrimidines
18. The antimicrobial activities of trimethoprim and sulfonamides
19. Drug therapy reviews: Trimethoprim-sulfamethoxazole
20. The clinical problems of bacterial resistance to the new quinolones
21. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas
22. Emerging patterns of microbial resistance
23. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins
24. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
25. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum
26. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum
27. The biosynthesis of folic acid. VIII. Purification and properties of the enzyme that catalyzes the production of formate from carbon atom 8 of guanosine triphosphate
28. Atomic structure of GTP cyclohydrolase I
29. Zinc plays a key role in human and bacterial GTP cyclohydrolase I
30. Active site topology and reaction mechanism of GTP cyclohydrolase I
31. Biosynthesis of pteridines. Stopped-flow kinetic analysis of GTP cyclohydrolase I
32. Biosynthesis of pteridines in Escherichia coli. Structural and mechanistic similarity of dihydroneopterin-triphosphate epimerase and dihydroneopterin aldolase
33. Crystal structure of 7,8-dihydroneopterin triphosphate epimerase
34. Purification, cloning, and functional expression of dihydroneopterin triphosphate 2′-epimerase from Escherichia coli
35. Enzymic characterization of Bacillus subtilis GTP cyclohydrolase I. Evidence for a chemical dephosphorylation of dihydroneopterin triphosphate
36. Crystal structure and reaction mechanism of 7,8-dihydroneopterin aldolase from Staphylococcus aureus
37. A vibrational structure of 7,8-dihydrobiopterin bound to dihydroneopterin aldolase
38. Inhibitors of folate biosynthesis. 1. Inhibition of dihydroneopterin aldolase by pteridine derivatives
39. The enzymatic synthesis of folate-like compounds from hydroxymethyldihydropteridine pyrophosphate
40. A bifunctional protein in the folate biosynthetic pathway of Streptococcus pneumoniae with dihydroneopterin aldolase and hydroxymethyldihydropterin pyrophosphokinase activities
41. Crystal structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, a potential target for the development of novel antimicrobial agents
42. 2.0 A X-ray structure of the ternary complex of 7,8dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue
43. The structure and function of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Haemophilus influenzae
44. Catalytic center assembly of HPPK as revealed by the crystal structure of a ternary complex at 1.25 A resolution
45. Equilibrium and kinetic studies of substrate binding to 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Escherichia coli
46. Unusual conformational changes in 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as revealed by x-ray crystallography and NMR
47. Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: Synthesis and biochemical and crystallographic studies
48. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase
49. Structure and function of the dihydropteroate synthase from Staphylococcus aureus
50. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: New insight into the enzymatic mechanism and sulfa-drug action
51. The structure and evolution of alpha/beta barrel proteins
52. Dihydropteroate synthase from Streptococcus pneumoniae: Characterization of substrate binding order and sulfonamide inhibition
53. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines
54. Inhibitors of dihydropteroate synthase: Substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues
55. Regulatory role of oxidized and reduced pteroylpolyglutamates
56. Regulation of folate and one-carbon metabolism in mammalian cells. I. Folate metabolism in Chinese hamster ovary cells expressing Escherichia coli or human folylpoly-gamma-glutamate synthetase activity
57. Mutagenesis of the Lactobacillus casei folylpolyglutamate synthetase gene at essential residues resembling an ATP binding site
58. Folylpoly-gamma-glutamate synthetase-dihydrofolate synthetase. Cloning and high expression of the Escherichia coli folC gene and purification and properties of the gene product
59. Pteroylpoly(gamma-glutamate) synthesis by Corynebacterium species. Purification and properties of folypoly(gamma-glutamate) synthetase
60. A bifunctional dihydrofolate synthetase - Folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria
61. Cloning and characterization of the Neisseria gonorrhoeae MS11 folC gene
62. Purification and properties of Lactobacillus casei folylpoly-gamma-glutamate synthetase
63. Structural homologies with ATP-and folate-binding enzymes in the crystal structure of folylpolyglutamate synthetase
64. Folate-binding triggers the activation of folylpolyglutamate synthetase
65. Structural and functional similarities in the ADP-forming amide bond ligase superfamily: Implications for a substrate-induced conformational change in folylpolyglutamate synthetase
66. Dihydrofolate synthetase and folylpolyglutamate synthetase: Direct evidence for intervention of acyl phosphate intermediates
67. Mechanism-based inhibition of human folylpolyglutamate synthetase: Design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate
68. A simple radioassay for dihydrofolate synthetase activity in Escherichia coli and its application to an inhibition study of new pteroate analogs
69. Inhibition of dihydrofolate synthetase from Neisseria gonorrhoeae by dihydropteroate and dihydrofolate derivatives
70. Characterization and inhibition of dihydrofolate synthetase from Neisseria gonorrhoeae
71. Channeling of substrates and intermediates in enzyme-catalysed reactions
72. The molecular basis of substrate channeling
73. Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase
74. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase
75. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
76. SWISS-MODEL and Swiss-Pdb viewer: An environment for comparative protein modelling